GlassScriptPhysician profile
Michael Victor
NPI 1205553252
$1,122.81
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,092 · 2024: $30.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.97 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $173.97 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $171.37 | 2023 | Austedo, Austedo Xr |
| Alkermes, INC. | $157.27 | 2023 | Aristada, Lybalvi, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $146.90 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $103.71 | 2023 | Spravato |
| Neurocrine Biosciences, INC. | $101.11 | 2023-2024 | Ingrezza |
| Abbvie INC. | $64.24 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.26 | 2023 | Trintellix |
| Lundbeck LLC | $49.96 | 2023 | Rexulti, Brintellix |
| Supernus Pharmaceuticals, INC. | $37.64 | 2023 | |
| Vanda Pharmaceuticals INC. | $24.40 | 2023 | Hetlioz, Fanapt |
| Axsome Therapeutics, INC. | $22.65 | 2023 | Auvelity |
| Biogen, INC. | $17.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Victor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.